Mid-term follow-up of stenting in chronic mesenteric ischaemia: a review of six cases

Sharkawi, Musa A.; Alfadhel, H. E.; Burns, Michael; Given, Mark F.; Lee, M. J.

doi:10.1007/s11845-013-0987-x

Cited by 3 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although PTA with stenting is restricted by an increased risk of restenosis, using covered stents has outstanding patency rates [ 14 ]. The most common complications of endovascular mesenteric revascularization are hematoma, pseudoaneurysm, or thrombosis at the access site [ 15 , 16 ].…”

Section: Discussionmentioning

confidence: 99%

A Case of Chronic Mesenteric Ischemia Due to Celiac and Mesenteric Artery Thrombosis

Malik,

Thomas,

Zafar

et al. 2023

Cureus

View full text Add to dashboard Cite

Chronic mesenteric ischemia (CMI) is uncommon and accounts for approximately 5% of cases. CMI presents with non-specific symptoms, making it difficult to diagnose, and requires complex management involving interprofessional teams. We present the case of a 66-year-old female who presented with postprandial abdominal pain, vomiting, sitophobia, and weight loss. Investigations showed raised inflammatory markers, and plain film X-ray and endoscopy showed no significant findings. CT angiogram showed celiac and mesenteric artery thrombosis. The patient proceeded to have endovascular revascularization. With this case, we highlight the importance of considering CMI in an elderly patient with a history of microvascular disease or risk factors presenting with postprandial abdominal pain and weight loss. Early diagnosis and timely intervention are imperative for a good prognosis.

show abstract

Section: Discussionmentioning

confidence: 99%

A Case of Chronic Mesenteric Ischemia Due to Celiac and Mesenteric Artery Thrombosis

Malik,

Thomas,

Zafar

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

Endovascular Therapy for Chronic Mesenteric Ischemia

Foley

Rogers

2016

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

Chronic mesenteric ischemia (CMI) most commonly occurs as a consequence of multivessel atherosclerotic disease of the mesenteric vasculature. Risk factors include smoking, hypertension, dyslipidemia, and advanced age, and women are more commonly affected than men. The clinical presentation of CMI is characterized by postprandial abdominal pain and weight loss. Left untreated, patients often develop severe malnutrition. Current consensus guidelines recommend secondary prevention medications such as statins and aspirin for all patients with known atherosclerosis to reduce the risk of stroke and MI, but data specific to medical therapy in CMI are lacking. To date, no medical therapy has been proven to be effective in preventing the progression of mesenteric atherosclerosis. Revascularization through surgical bypass is associated with significant perioperative morbidity and mortality. The evolution of endovascular techniques and equipment has made catheter-based therapy a first-line option for revascularization in CMI.

show abstract

Comparing Endovascular Revascularization to Open Surgical Revascularization for Chronic Mesenteric Ischemia

Alqahtani

Albilasi

Alenzi

et al. 2022

Indian Journal of Vascular and Endovascular Surgery

View full text Add to dashboard Cite

Although the incidence of chronic mesenteric ischemia (CMI) is uncommon, it could become life threatening. With improvements in diagnostic imaging and endovascular therapy over the past few decades, the treatment of CMI has evolved. Even though endovascular revascularization for CMI is prominent, it is unclear if the early advantages outweigh the long-term patency rates. This study conducts a systematic review and meta-analysis to present comprehensive insights into the validity of endovascular revascularization versus open revascularization as effective therapeutic modalities. Studies up to 2022 were searched in MEDLINE, Cochrane Database of Systematic Reviews, Scopus, and Embase. Additionally, references from earlier studies and review papers were manually searched for additional relevant reports. At least two authors examined all the results, making sure they fit the inclusion and exclusion criteria. In the event of disagreement, the authors were able to reach an understanding. Open revascularization is superior to endovascular approaches in maintaining vessel patency and reducing symptoms over the long term. Perioperative problems are more common in patients undergoing open procedures. Each patient's anatomy and physiology call for a different revascularization approach to be applied in treating this condition.

show abstract

Mid-term follow-up of stenting in chronic mesenteric ischaemia: a review of six cases

Abstract: Stenting of mesenteric vessels has shown excellent early and mid-term clinical success in selected patients. Though no direct comparison with open revascularization surgery was performed in this case series, technical and mid-term clinical success is promising.

Cited by 3 publications

References 9 publications

A Case of Chronic Mesenteric Ischemia Due to Celiac and Mesenteric Artery Thrombosis

A Case of Chronic Mesenteric Ischemia Due to Celiac and Mesenteric Artery Thrombosis

Endovascular Therapy for Chronic Mesenteric Ischemia

Comparing Endovascular Revascularization to Open Surgical Revascularization for Chronic Mesenteric Ischemia

Contact Info

Product

Resources

About